Pipeline Overview

PRODUCT

TYPE

TARGET

CANCER

DISCOVERY

PRE-CLINICAL

PHASE 1

PHASE 2

PHASE 3

Vaccine

Breast
(TNBC)

Phase 3 TNBC Study

Vaccine

NSCLC

Prodrug

Multiple Cancers

ADC

TROP2

Multiple Cancers

ADC

TROP2

Multiple Cancers

ADC

Nectin4

Multiple Cancers

ADC

HER2

Multiple Cancers

BsADC

ADC

TROP2,
HER2

Multiple Cancers

Last updated on Dec 27, 2023